CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced it will participate in a fireside chat at the following investor conferences: Stifel 2021 Virtual Healthcare Conference on Monday, November 15, 2021 at 9:20 a.m. EST Jefferies London Healthcare Conference on Tuesday, November 16, 2021 at [...]